Establishment Labs Holdings (ESTA) Accumulated Depreciation & Amortization (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Accumulated Depreciation & Amortization of $1.6 million in Q1 2026, down 74.19% quarter-over-quarter from $6.2 million in Q4 2025, and little changed on a YoY basis from $1.6 million in Q1 2025.
Establishment Labs Holdings (ESTA) Accumulated Depreciation & Amortization (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Accumulated Depreciation & Amortization history runs 10 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization changed 0.0% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (changed 0.0% YoY), while the FY2025 annual figure was $6.2 million, up 31.91% from the prior year.
- Accumulated Depreciation & Amortization was $1.6 million for Q1 2026 at Establishment Labs Holdings, down from $6.2 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $12.5 million in Q1 2022 to a low of $600000.0 in Q2 2022.
- Historically, Accumulated Depreciation & Amortization has averaged $2.5 million across 5 years, with a median of $1.5 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation & Amortization slumped 95.21% in 2023, then soared 255.56% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $2.5 million in 2022, then advanced by 12.0% to $2.8 million in 2023, then jumped by 67.86% to $4.7 million in 2024, then jumped by 31.91% to $6.2 million in 2025, then tumbled by 74.19% to $1.6 million in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $1.6 million (Q1 2026), $6.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.44 Bn | 2.37 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |